Small Cell Lung Cancer (SCLC)Фаза 2NCT07149363
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Durvalumab 50 MG/ML
73 Phase 2 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Lung and thoracic73 studies
Small Cell Lung Cancer (SCLC)Фаза 2NCT07149363
Durvalumab 50 MG/ML
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorФаза 2NCT07874490
Osimertinib, Cyclosporine A (CsA), ctDNA Biopsy Panel
Non-small Cell Lung CancerФаза 2NCT04302025
Alectinib, Entrectinib, Vemurafenib, Cobimetinib
Non-Small Cell Lung CancerФаза 2NCT01639508Papers
Cabozantinib
Advanced Lung Non-Small Cell CarcinomaФаза 2NCT07322341
Atezolizumab, CXCR1/2 Inhibitor SX-682, Biospecimen Collection, Computed Tomography
Recurrent Lung Non-Small Cell CarcinomaФаза 2NCT07393555
Biospecimen Collection, Computed Tomography, Ivonescimab, Magnetic Resonance Imaging
Lung Non-Small Cell CarcinomaФаза 2NCT06116682
Amivantamab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging
Extensive-stage Small-cell Lung CancerФаза 2NCT05588388
Bevacizumab
Lung NeoplasmФаза 2NCT06780098
R-DXD, I-DXD, Docetaxel, Rescue Medications
Non-small Cell Lung Cancer Stage IIIФаза 2NCT06449313
Cemiplimab-Rwlc
Non-small Cell Lung Cancer (NSCLC)Фаза 2NCT07288177
Rina-S
Thymus CarcinomaФаза 2NCT06980077
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ivonescimab
Non Small Cell Lung CancerФаза 2NCT06907615
HLX43 DOSE 1 (2.0 mg/kg), HLX43 DOSE 2 (2.5 mg/kg)
Carcinoma, Non-small-Cell LungФаза 2NCT05498428
Amivantamab, Lazertinib, Carboplatin, Pemetrexed
Carcinoma, Non-Small-Cell LungФаза 2NCT06667076
Amivantamab, Lazertinib, Chemotherapy: Pemetrexed, Chemotherapy: Carboplatin
Carcinoma, Non-Small-Cell LungФаза 2NCT06667908
JNJ-90301900, Durvalumab, Concurrent Chemo/Radiation Therapy (cCRT), Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin
Carcinoma, Non-Small-Cell LungФаза 2NCT07586202
Amivantamab, Lazertinib, Carboplatin, Pemetrexed
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)Фаза 2NCT06693336
SMS001
Squamous Cell Lung CancerФаза 2NCT05607108
ZEN003694
Non-small Cell Lung CancerФаза 2NCT06745882
Cisplatin, Carboplatin, Pemetrexed, Pembrolizumab
Carcinoma, Non-Small-Cell LungФаза 2NCT06855771
BMS-986504, Izalontamab Brengitecan
Extensive-stage Small-cell Lung CancerФаза 2NCT07459634
Lurbinectedin, Durvalumab
Resectable Lung Non-Small Cell CarcinomaФаза 2NCT06008730
Biospecimen Collection, Proton Beam Radiation Therapy, Radiology, Treatment Planning
Lung CancerФаза 2NCT07630168
PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM, PD-1/PD-L1 inhibitor monotherapy - 4 cycles after 3 PM, PD-1 inhibitor monotherapy - 2 cycles before 12:00PM, PD-1 inhibitor monotherapy - 2 cycles after 3 PM